|
1
|
Hafez AR, Alenazi AM, Kachanathu SJ,
Alroumi AM and Mohamed ES: Knee osteoarthritis: A review of
literature. Phys Med Rehabil Int. 1:1–8. 2014.
|
|
2
|
Jinks C, Jordan K, Ong BN and Croft P: A
brief screening tool for knee pain in primary care (KNEST). 2.
Results from a survey in the general population aged 50 and over.
Rheumatology (Oxford). 43:55–61. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Johnson VL and Hunter DJ: The epidemiology
of osteoarthritis. Best Pract Res Clin Rheumatol. 28:5–15. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu Q, Niu J, Li H, Ke Y, Li R, Zhang Y
and Lin J: Knee symptomatic osteoarthritis, walking disability,
NSAIDs use and all-cause mortality: Population-based wuchuan
osteoarthritis study. Sci Rep. 7:33092017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Davis AM: Osteoarthritis year in review:
Rehabilitation and outcomes. Osteoarthritis Cartilage. 20:201–206.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bannuru RR, Osani M, Vaysbrot EE and
McAlindon TE: Comparative safety profile of hyaluronic acid
products for knee osteoarthritis: A systematic review and network
meta-analysis. Osteoarthritis Cartilage. 24:2022–2041. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Herrera-Espiñeira C, Escobar A,
Navarro-Espigares JL, Castillo Jde D, García-Pérez L and
Godoy-Montijano A: Total knee and hip prosthesis: Variables
associated with costs. Cir Cir. 81:207–213. 2013.(In Spanish).
PubMed/NCBI
|
|
8
|
Ethgen O, Bruyère O, Richy F, Dardennes C
and Reginster JY: Health-related quality of life in total hip and
total knee arthroplasty. A qualitative and systematic review of the
literature. J Bone Joint Surg Am 86-A. 963–974. 2004. View Article : Google Scholar
|
|
9
|
Robinson JC, Pozen A, Tseng S and Bozic
KJ: Variability in costs associated with total hip and knee
replacement implants. J Bone Joint Surg Am. 94:1693–1698. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garcia JP and Paz Michel BA: Formulation
for regeneration of bone, cartilage, teeth, and periodontium and
treatment of tumors and cysts. US Patent No. 9089580 B1. 2015.
|
|
11
|
Delgado-Enciso I, Paz-Garcia J,
Rodriguez-Hernandez A, Madrigal-Perez VM, Cabrera-Licona A,
Garcia-Rivera A, Soriano-Hernandez AD, Cortes-Bazan JL,
Galvan-Salazar HR, Valtierra-Alvarez J, et al: A promising novel
formulation for articular cartilage regeneration: Preclinical
evaluation of a treatment that produces SOX9 overexpression in
human synovial fluid cells. Mol Med Rep. 17:3503–3510.
2018.PubMed/NCBI
|
|
12
|
Farkas B, Kvell K, Czömpöly T, Illés T and
Bárdos T: Increased chondrocyte death after steroid and local
anesthetic combination. Clin Orthop Relat Res. 468:3112–3120. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sekiya I, Tsuji K, Koopman P, Watanabe H,
Yamada Y, Shinomiya K, Nifuji A and Noda M: SOX9 enhances aggrecan
gene promoter/enhancer activity and is up-regulated by retinoic
acid in a cartilage-derived cell line, TC6. J Biol Chem.
275:10738–10744. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reiter I, Tzukerman M and Maor G:
Spontaneous differentiating primary chondrocytic tissue culture: A
model for endochondral ossification. Bone. 31:333–339. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hadzir SN, Ibrahim SN, Abdul Wahab RM,
Zainol Abidin IZ, Senafi S, Ariffin ZZ, Abdul Razak M and Zainal
Ariffin SH: Ascorbic acid induces osteoblast differentiation of
human suspension mononuclear cells. Cytotherapy. 16:674–682. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ogston N, Harrison AJ, Cheung HF, Ashton
BA and Hampson G: Dexamethasone and retinoic acid differentially
regulate growth and differentiation in an immortalised human clonal
bone marrow stromal cell line with osteoblastic characteristics.
Steroids. 67:895–906. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gentili C, Bianco P, Neri M, Malpeli M,
Campanile G, Castagnola P, Cancedda R and Cancedda FD: Cell
proliferation, extracellular matrix mineralization, and
ovotransferrin transient expression during in vitro differentiation
of chick hypertrophic chondrocytes into osteoblast-like cells. J
Cell Biol. 122:703–712. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Skillington J, Choy L and Derynck R: Bone
morphogenetic protein and retinoic acid signaling cooperate to
induce osteoblast differentiation of preadipocytes. J Cell Biol.
159:135–146. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Benya PD, Brown PD and Padilla SR:
Microfilament modification by dihydrocytochalasin B causes retinoic
acid-modulated chondrocytes to reexpress the differentiated
collagen phenotype without a change in shape. J Cell Biol.
106:161–170. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Temu TM, Wu KY, Gruppuso PA and
Phornphutkul C: The mechanism of ascorbic acid-induced
differentiation of ATDC5 chondrogenic cells. Am J Physiol
Endocrinol Metab. 299:E325–E334. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zur Nieden NI, Kempka G, Rancourt DE and
Ahr HJ: Induction of chondro-, osteo- and adipogenesis in embryonic
stem cells by bone morphogenetic protein-2: Effect of cofactors on
differentiating lineages. BMC Dev Biol. 5:12005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen H, Wang H, Li B, Feng B, He X, Fu W,
Yuan H and Xu Z: Enhanced chondrogenic differentiation of human
mesenchymal stems cells on citric acid-modified chitosan hydrogel
for tracheal cartilage regeneration applications. RSC Adv.
8:16910–16917. 2018. View Article : Google Scholar
|
|
23
|
Mahmod SA, Snigh S, Djordjevic I, Yee YM,
Yusof R, Ramasamy TS and Rothan HA: Phytoestrogen (Daidzein)
promotes chondrogenic phenotype of human chondrocytes in 2D and 3D
culture systems. Tissue Eng Regen Med. 14:103–112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Delgado-Enciso I, Paz-Garcia J,
Valtierra-Alvarez J, Preciado-Ramirez J, Almeida-Trinidad R,
Guzman-Esquivel J, Mendoza-Hernandez MA, Garcia-Vega A,
Soriano-Hernandez AD, Cortes-Bazan JL, et al: A phase I–II
controlled randomized trial using a promising novel cell-free
formulation for articular cartilage regeneration as treatment of
severe osteoarthritis of the knee. Eur J Med Res. 23:522018.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ringdahl E and Pandit S: Treatment of knee
osteoarthritis. Am Fam Physician. 83:1287–1292. 2011.PubMed/NCBI
|
|
26
|
Center for Disease Control and Prevention,
. Defining adult overweight and obesity. Centers Dis Control Prev.
pp8–9. 2016.
|
|
27
|
Tubach F, Ravaud P, Baron G, Falissard B,
Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der
Heijde D and Dougados M: Evaluation of clinically relevant changes
in patient reported outcomes in knee and hip osteoarthritis: The
minimal clinically important improvement. Ann Rheum Dis. 64:29–33.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Englbrecht M, Tarner IH, van der Heijde
DM, Manger B, Bombardier C and Müller-Ladner U: Measuring pain and
efficacy of pain treatment in inflammatory arthritis: A systematic
literature review. J Rheumatol Suppl. 90:3–10. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Delgado-Enciso I, Paz-Michel B, Melnikov
V, Guzman-Esquivel J, Espinoza-Gomez F, Soriano-Hernandez AD,
Rodriguez-Sanchez IP, Martinez-Fierro ML, Ceja-Espiritu G,
Olmedo-Buenrostro BA, et al: Smoking and female sex as key risk
factors associated with severe arthralgia in acute and chronic
phases of chikungunya virus infection. Exp Ther Med. 15:2634–2642.
2018.PubMed/NCBI
|
|
30
|
Reginster JY, Dudler J, Blicharski T and
Pavelka K: Pharmaceutical-grade Chondroitin sulfate is as effective
as celecoxib and superior to placebo in symptomatic knee
osteoarthritis: The ChONdroitin versus CElecoxib versus placebo
trial (CONCEPT). Ann Rheum Dis. 76:1537–1543. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
van der Wees PJ, Wammes JJ, Akkermans RP,
Koetsenruijter J, Westert GP, van Kampen A, Hannink G, de
Waal-Malefijt M and Schreurs BW: Patient-reported health outcomes
after total hip and knee surgery in a Dutch University Hospital
Setting: Results of twenty years clinical registry. BMC
Musculoskelet Disord. 18:972017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Revicki D, Hays RD, Cella D and Sloan J:
Recommended methods for determining responsiveness and minimally
important differences for patient-reported outcomes. J Clin
Epidemiol. 61:102–109. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Escobar A, García Pérez L,
Herrera-Espiñeira C, Aizpuru F, Sarasqueta C, Gonzalez Sáenz de
Tejada M, Quintana JM and Bilbao A: Total knee replacement; minimal
clinically important differences and responders. Osteoarthritis
Cartilage. 21:2006–2012. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kvien TK, Heiberg T and Hagen KB: Minimal
clinically important improvement/difference (MCII/MCID) and patient
acceptable symptom state (PASS): what do these concepts mean? Ann
Rheum Dis. 66 (Suppl 3):iii40–iii41. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sowers MR and Karvonen-Gutierrez CA: The
evolving role of obesity in knee osteoarthritis. Curr Opin
Rheumatol. 22:533–537. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Koskinen A, Vuolteenaho K, Nieminen R,
Moilanen T and Moilanen E: 011 Proinflammatory and catabolic role
of leptin in osteoarthritis. Correlation with IL-6, MMP-1 and MMP-3
in synovial fluid and effects in human OA cartilage. Osteoarthritis
Cartilage. 18:S13–S14. 2010. View Article : Google Scholar
|
|
37
|
Lago R, Gomez R, Otero M, Lago F, Gallego
R, Dieguez C, Gomez-Reino JJ and Gualillo O: A new player in
cartilage homeostasis: Adiponectin induces nitric oxide synthase
type II and pro-inflammatory cytokines in chondrocytes.
Osteoarthritis Cartilage. 16:1101–1109. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Simopoulou T, Malizos KN, Iliopoulos D,
Stefanou N, Papatheodorou L, Ioannou M and Tsezou A: Differential
expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA
between advanced and minimally affected osteoarthritic cartilage;
effect on cartilage metabolism. Osteoarthritis Cartilage.
15:872–883. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Toussirot E, Streit G and Wendling D: The
contribution of adipose tissue and adipokines to inflammation in
joint diseases. Curr Med Chem. 14:1095–1100. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Presle N, Pottie P, Dumond H, Guillaume C,
Lapicque F, Pallu S, Mainard D, Netter P and Terlain B:
Differential distribution of adipokines between serum and synovial
fluid in patients with osteoarthritis. Contribution of joint
tissues to their articular production. Osteoarthritis Cartilage.
14:690–695. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hunter DJ, Sharma L and Skaife T:
Alignment and osteoarthritis of the knee. J Bone Joint Surg Am. 91
(Suppl 1):S85–S89. 2009. View Article : Google Scholar
|
|
42
|
Dawson L, Zarin DA, Emanuel EJ, Friedman
LM, Chaudhari B and Goodman SN: Considering usual medical care in
clinical trial design. PLoS Med. 6:e10001112009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Arboleya LR, DE LA Figuera E, García Ms
and Aragón B; Grupo De Estudio Vicoxx, : Tratamiento sintomático de
la artrosis: Patrón de utilización de antiinflamatorios no
esteroides en los centros de salud españoles. Rev Española
Reumatol. 29:300–307. 2002.
|
|
44
|
Da Costa BR, Reichenbach S, Keller N,
Nartey L, Wandel S, Jüni P and Trelle S: RETRACTED: Effectiveness
of non-steroidal anti-inflammatory drugs for the treatment of pain
in knee and hip osteoarthritis: A network meta-analysis. Lancet.
387:2093–2105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bannuru RR, Schmid CH, Kent DM, Vaysbrot
EE, Wong JB and McAlindon TE: Comparative effectiveness of
pharmacologic interventions for knee osteoarthritis: A systematic
review and network meta-analysis. Ann Intern Med. 162:46–54. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lapane KL, Yang S, Driban JB, Liu SH, Dubé
CE, McAlindon TE and Eaton CB: Effects of prescription nonsteroidal
antiinflammatory drugs on symptoms and disease progression among
patients with knee osteoarthritis. Arthritis Rheumatol. 67:724–732.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yaxley J and Litfin T: Non-steroidal
anti-inflammatories and the development of analgesic nephropathy: A
systematic review. Ren Fail. 38:1328–1334. 2016. View Article : Google Scholar : PubMed/NCBI
|
